Danaher's approach to Catalent values it at a significant premium, the report said, adding that unclear how Catalent will proceed or whether it is receptive to a takeover offer. A deal is not ...

Notably, Bloomberg earlier this month reported that Danaher was interested in acquiring life sciences firm Catalent (CTLT). Although the initial reaction to this news was mixed, the market should ...

(Bloomberg) -- Life sciences company Danaher Corp. has expressed takeover interest in contract manufacturer Catalent Inc., according to people familiar with the matter. Most Read from Bloomberg ...

Danaher (DHR) stock is rising after the company announced it will acquire Pall Corp. (PLL) and split itself into two companies. Danaher (DHR) stock is rising after the company announced it will ...

Danaher Corp. will split into two companies on July 2, completing the separation into two two independent, publicly traded ventures that it announced in May 2015. The split will free the two entities ...

Pall Corp. (PLL) stock is rising after the company said it will be acquired by Danaher (DHR) for $13.8 billion. Pall Corp. (PLL) stock is rising after the company said it will be acquired by ...

Aristotle Core Equity Strategy highlighted stocks like Catalent, Inc. (NYSE:CTLT) in its Q4 2022 investor letter. Headquartered in Somerset, New Jersey, Catalent, Inc. (NYSE:CTLT) is a drug ...

Life sciences and medical diagnostics company Danaher (DHR) reported better-than-expected earnings and revenue for the fourth quarter. We view the dip in the stock as unjustified and an opportunity.

Danaher (DHR) closed at $247.97 in the latest trading session, marking a -0.08% move from the prior day. This move lagged the S&P 500's daily gain of 0.17%. At the same time, the Dow added 0.6% ...

Danaher Corporation DHR is backed by multiple tailwinds despite headwinds from adverse foreign currency movements, supply chain issues and cost inflation. This Zacks Rank #3 (Hold) company is ...